Evidence has shown that mice with pancreatic tumor carrying a dominant negative ATG4B mutant displayed a significantly higher number of CD68+ macrophages in the tumors compared to mice carrying wild-type ATG4B [37]. This evidence concerns the gene ATG4B and pancreatic neoplasm.